What is Botanix Pharmaceuticals Limited (BXPHF)?

Botanix Pharmaceuticals Limited (BXPHF) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of BXPHF?

The current price of BXPHF is $0.01. Prices are updated in real time on Stocks360.

What is BXPHF's price-to-earnings (PE) ratio?

BXPHF's trailing twelve-month PE ratio is -0.34, based on current price and earnings per share data available on Stocks360.

What is BXPHF's market capitalization?

BXPHF's market capitalization is $19,330,823.00, placing it in the small-cap tier.

Botanix Pharmaceuticals Limited (BXPHF)

Stock analysis · OTC · Healthcare · Biotechnology

$0.01

Market Cap

$19.33M

PE (TTM)

-0.34

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.86

Day Range

$0.01 – $0.01

52-wk Range

$0.01 – $0.11

Avg Volume

N/A

Volume

46.00K

Botanix Pharmaceuticals Limited (BXPHF) is a publicly traded company in the Healthcare sector. Latest price: $0.01. Market cap $19.33M. Trailing PE -0.34. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $0.09 2026-10-28 · $0.01 (-92.02%)

Earnings

Most Recent

Aug 26, 2026

EPS $-0.01 vs est. $-0.01

Beat by $0.00

Next Earnings

Mar 3, 2027

EPS estimate $-0.01

Proprietary Signals

Signal snapshot temporarily unavailable.

About Botanix Pharmaceuticals Limited

Botanix Pharmaceuticals Ltd is a dermatology company that focuses on developing safe and effective topical treatments for serious skin conditions. The company's product pipeline includes treatments for conditions such as moderate to severe acne, atopic dermatitis, rosacea, and axillary hyperhidrosis. It has an exclusive license to use a proprietary drug delivery system for skin diseases.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.34×
P/S (TTM)	0.64×
P/B	0.41×
P/FCF (TTM)	-0.34×
EV / EBITDA	-0.00×
EV / Sales	0.00×
Earnings Yield	-265.80%
Free Cash Flow Yield	-294.73%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$27.21K
Revenue (TTM)	$34.51M
Net Income (TTM)	-$58.26M
Free Cash Flow (TTM)	-$61.76M
Net Debt	-$21.89M
Working Capital	$49.30M
Gross Margin	-172.20%
Operating Margin	-200.82%
Net Margin	-202.15%
Return on Equity	-118.74%
Return on Invested Capital	-77.62%